Neuroscience
Position Details (Master's)
You will study topics such as the principles of drug design and development, in particular the key steps involved in the drug discovery and development process, and learn about clinical trial design and methodology. You will also critically discuss the challenges associated with developing better therapies in various diseases and gain insight into the regulatory environment.
Furthermore, you will be able to gain state of the art expertise in areas such as brain tumours, pain, neurodegenerative diseases and neuroinflammation, neurotrauma and stem cells therapeutics, and this will be delivered through specialised interactive sessions with world leading experts in the field.
What sets the Neuroscience program from Queen Mary University of London apart is its unique emphasis on the present clinical challenges in neurological disease. This program ties together the scientific, clinical, and patient care aspects of neurological disease in a unique way, which makes our course quite different from other courses.
Career paths
Many of its graduates go on to prestigious positions within the NHS (e.g. Airedale General Hospital, St George's Hospital, University College Hospital, University Hospital of Burton and Derby), the Oxford Vaccine Group, and other non-medical employment.
Many are working in positions such as Doctor, Laboratory Assistant, Clinical Trials Data Manager, Trial Coordinator, Pharmacy Assistant Technical Officer, Research Scientists in academia or industry, Independent Scientific Investigators, Medical and Science writers, and Marketing and Communications roles.
Others have returned to their clinical work or study, as PhD students or MBBS students at institutions such as Queen Mary or the University of Sunderland.
Courses include
- Tissue-specific Stem Cells
- Neurodegenerative Diseases
- Induced Pluripotent Stem Cells and Genome Engineering
- Pain and Epilepsy
- Neurotrauma and Stroke
Queen Mary University of London
On Campus (Full Time)
See Position Description
Dec 2025